United States Flow Cytometer Market Insight
Published: 22 May 2026 | Report Format: Electronic (PDF)
In the US, the flow cytometer market size is expanding about 7.9% CAGR, pushed by a steady rise in the prevalence of long-term diseases, plus higher demand for accurate diagnostics and also broader adoption of advanced cell analysis methods across clinical diagnostics, immunology, oncology, and biomedical research.
U.S.Flow Cytometer Market Insights Forecasts to 2035
- The US Flow Cytometer Market Size Was Estimated at USD 2.21 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.9% from 2025 to 2035
- The US Flow Cytometer Market Size is Expected to Reach USD 4.73 Billion by 2035
Notable Insights for U.S.Flow Cytometer Market
- By product type, the instruments segment dominated the market, generating approximately USD 0.78 Billion in revenue in 2024.
- Through application, the clinical diagnostics and oncology research category will grow at the highest rate due to the growing prevalence of cancer cases and increased use of immunophenotyping and biomarker detection techniques.
- About 67% of the biomedical labs in the US use flow cytometry systems for deeper cell analysis and also for disease diagnostics, and it’s close to that 61% figure where healthcare institutions depend on automated flow cytometers, so they can raise testing accuracy, track disease progression, and streamline the clinical workflow in a more tidy way.
Download the eBook (ToC)
- More and more, there is a stronger push toward precision medicine and immunotherapy research, which is kind of boosting the US flow cytometer market through advanced spectral flow cytometry plus AI- enabled analysis systems.
Why Buy This Report
- Get a full understanding of the US flow cytometer market in terms of its size, growth drivers, competitive structure, and future forecast analysis that influence the clinical diagnostics and biomedical research industry.
- Understand the growing demand for automated cell analyzers, immunophenotyping techniques, and advanced diagnostic tools among hospitals, diagnostic centers, drug manufacturers, and research organizations in the US.
- Get insight into the high-growth investment and the opportunities through the in-depth analysis of technology trends, AI-powered flow cytometers, product innovation, and other important developments influencing the US flow cytometer industry.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Flow Cytometer market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United StatesFlow Cytometer Market
- Becton, Dickinson and Company
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Sysmex Corporation
- Cytek Biosciences
- Sony Biotechnology Inc.
- Others
Recent Developments:
- In March 2026, Cytek Biosciences launched the new generation of spectral flow cytometry devices with improved multi-parameter analysis features for diagnostic and immunological research purposes in the US.
- In September 2025, Thermo Fisher Scientific Inc. increased its range of automated flow cytometers by introducing the latest generation of AI-powered cell analyzers for diagnostics and oncology research purposes.
Market Segmentation:
United StatesFlow Cytometer Market, By Product Type
- Instruments
- Reagents & Consumables
- Software
- Accessories
- Services
United States Flow Cytometer Market, By Technology
- Cell-based Flow Cytometry
- Bead-based Flow Cytometry
United States Flow Cytometer Market, By End User
- Clinical Diagnostics
- Oncology Research
- Immunology
- Drug Discovery
- Stem Cell Research
- Others
Expert Views:
The US flow cytometer market is set for ongoing growth, partly because healthcare providers and research institutions are more and more needing advanced cell analysis systems for precision diagnostics and biomedical research. In other words, it’s not just that demand is rising, it’s also that the needs are shifting toward better, more reliable results. Specialists also say that automated instruments and clinical diagnostics use will end up leading the market, but there’s more, innovations like spectral flow cytometry, AI-powered analytics, and multi-omics research technologies will keep pushing expansion forward.
Author: Govind and Krishna By Spherical Insights and Consulting